Yolanda Guerra Mendoza

Ad35.CS.01 - RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults

Christian F. Ockenhouse, Jason A. Regules, Donna Tosh et al. · PLoS ONE · 2015 · 93 citations · Full text

Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial

Halidou Tinto, Walter Otieno, Samwel Gesase et al. · The Lancet Infectious Diseases · 2019 · 68 citations

Vaccination, Vaccine Safety, Pediatric Epidemiology +10

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

Yolanda Guerra Mendoza, Elodie Garric, Amanda Leach et al. · Human Vaccines & Immunotherapeutics · 2019 · 65 citations · Full text

Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up

Nicolas Praet, Kwaku Poku Asante, Marie‐Cécile Bozonnat et al. · Malaria Journal · 2022 · 40 citations · Full text

Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial

Lucas Otieno, Martina Oneko, Walter Otieno et al. · The Lancet Infectious Diseases · 2016 · 34 citations · Full text

Vaccination, Vaccine Safety, Maternal Immunization +6